Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:selegiline
|
| gptkbp:ATCCode |
N04BD01
|
| gptkbp:contraindication |
concomitant use with meperidine
hypersensitivity to selegiline |
| gptkbp:drugClass |
monoamine oxidase B inhibitor
|
| gptkbp:form |
orally disintegrating tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zelapar
|
| gptkbp:manufacturer |
gptkb:Valeant_Pharmaceuticals
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:regulates |
approved
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness insomnia |
| gptkbp:usedFor |
gptkb:Parkinson's_disease
|
| gptkbp:bfsParent |
gptkb:Selegiline
gptkb:selegiline |
| gptkbp:bfsLayer |
7
|